ID
DB10740||
名称
Quercus gambelii pollen
描述
Quercus gambelii pollen is the pollen of the Quercus gambelii plant. Quercus gambelii pollen is mainly used in allergenic testing.
cas号
唯一标识码
9HC15X34LX
状态
一般参考文献


approved,
指示
药效学
作用机制
毒性
代谢
吸收
半衰期
分类
消除途径
种类
Cell-mediated Immunity

Increased Histamine Release

Increased IgG Production

Non-Standardized Pollen Allergenic Extract

盐类
蛋白质结合
清除
同义词
language:english; code:; name;Gambels oak pollen extract
国际品牌
配送量
产品
name:Arizona Gambel Oak Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-4460
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.001 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Arizona Gambel Oak Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-5447
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.05 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Arizona Gambel Oak Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-2479
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.1 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Arizona Gambel Oak Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-2481
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:0.05 g/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Arizona Gambel Oak Pollen
labeller:Greer Laboratories, Inc.
ndc-id:
ndc-product-code:22840-2480
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1981-09-15
ended-marketing-on:
dosage-form:Solution
strength:40000 [PNU]/1mL
route:Intradermal; Percutaneous; Subcutaneous
fda-application-number:BLA101833
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambel Oak
labeller:Antigen Laboratories, Inc.
ndc-id:
ndc-product-code:49288-0356
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-23
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102223
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambels Oak Pollen
labeller:Allermed Laboratories, Inc.
ndc-id:
ndc-product-code:49643-404
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1974-03-12
ended-marketing-on:
dosage-form:Injection
strength:0.05 g/1mL
route:Cutaneous; Intradermal; Subcutaneous
fda-application-number:BLA102211
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2855
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2859
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2857
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:40000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2860
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.1 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2853
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2858
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:0.05 g/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2854
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:10000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Gambil Oak
labeller:Nelco Laboratories, Inc.
ndc-id:
ndc-product-code:36987-2856
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:1972-08-29
ended-marketing-on:
dosage-form:Injection, solution
strength:20000 [PNU]/1mL
route:Intradermal; Subcutaneous
fda-application-number:BLA102192
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
混合物
name:Gambel Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambil Oak
ingredients:Quercus gambelii pollen
name:Gambels Oak Pollen
ingredients:Quercus gambelii pollen
name:Arizona Gambel Oak Pollen
ingredients:Quercus gambelii pollen
name:Arizona Gambel Oak Pollen
ingredients:Quercus gambelii pollen
name:Arizona Gambel Oak Pollen
ingredients:Quercus gambelii pollen
name:Arizona Gambel Oak Pollen
ingredients:Quercus gambelii pollen
name:Arizona Gambel Oak Pollen
ingredients:Quercus gambelii pollen
包装者
生产者
价格
受影响的生物体
剂量
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.001 g/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.05 g/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:0.1 g/1mL
form:Solution
route:Intradermal; Percutaneous; Subcutaneous
strength:40000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.05 g/1mL
form:Injection
route:Cutaneous; Intradermal; Subcutaneous
strength:0.05 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:0.1 g/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:10000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:20000 [PNU]/1mL
form:Injection, solution
route:Intradermal; Subcutaneous
strength:40000 [PNU]/1mL
atc代码
fda标签
化学品安全技术说明书
专利
食物相互作用
药物相互作用
序列
实验性质
外部标识符
resource:PubChem Substance
identifier:347910869
resource:RxCUI
identifier:852276
外部链接
路径
目标
载体
运输工具
药物反应
效应
不良反应